News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

STAAR Surgical Company (STAA) to Present at the Stephens Fall Investment Conference


11/9/2012 2:12:10 PM

MONROVIA, Calif., Nov. 8, 2012 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that it will participate in the Stephens Fall Investment Conference at the New York Palace Hotel in New York City. STAAR's presentation will be on Wednesday, November 14, 2012, at 9:00 am Eastern Time.

Barry G. Caldwell, President and CEO, will review the company's recent financial results and current business developments. Deborah Andrews, CFO, will also be attending.

STAAR will offer a live audio webcast of the roundtable discussion of the business on the Company's website, www.staar.com, under Investor Information. An archived replay of the presentation will be available for 30 days, also at www.staar.com.

About STAAR Surgical

STAAR, which has been dedicated solely to ophthalmic surgery for over 25 years, designs, develops, manufactures and markets implantable lenses for the eye. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR's lens used in refractive surgery as an alternative to LASIK is called an Implantable Collamer® Lens or "ICL." A lens used to replace the natural lens after cataract surgery is called an intraocular lens or "IOL." Over 300,000 Visian ICLs have been implanted to date; to learn more about the ICL go to: www.visianinfo.com. STAAR has approximately 300 full time employees and markets lenses in over 60 countries. Headquartered in Monrovia, CA, it manufactures in the following locations: Nidau, Switzerland; Ichikawa City, Japan; Aliso Viejo, CA; and Monrovia, CA. For more information, please visit the Company's website at www.staar.com or call 626-303-7902.

Collamer® is the registered trademark for STAAR's proprietary biocompatible collagen copolymer lens material.

CONTACT:

Investors

Media


EVC Group

EVC Group


Douglas Sherk, 415-652-9100

Amy Phillips


Jamar Ismail, 415-568-9348

412-327-9499


Jenifer Kirtland, 415-568-9349


SOURCE STAAR Surgical Company


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES